Presidio Management Group X LLC, 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 143,020 shares at $10.07 ($1.5M) on 2021-11-12, disclosed to the SEC on 2021-11-12.
Open-market sale of $1.5M EFTR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 893 | $10K | 0.7% |
| 2 | $11.00 | 27,892 | $307K | 20.5% |
| 3 | $10.44 | 1,054 | $11K | 0.7% |
| 4 | $10.44 | 32,946 | $344K | 22.9% |
| 5 | $10.44 | 32,946 | $344K | 22.9% |
| 6 | $10.37 | 373 |
| $4K |
| 0.3% |
| 7 | $10.37 | 11,644 | $121K | 8.1% |
| 8 | $10.37 | 11,644 | $121K | 8.1% |
| 9 | $10.07 | 372 | $4K | 0.2% |
| 10 | $10.07 | 11,628 | $117K | 7.8% |
| 11 | $10.07 | 11,628 | $117K | 7.8% |
| Total | $10.48 avg | 143,020 | $1.5M | 100% |
| Filing → |